Jan 14, 2022

ERA Neuron Call out now: “Cerebrovascular Diseases”!

The aim of the call is to facilitate multinational, collaborative research projects that will address important translational questions in the areas of stroke and other cerebrovascular diseases including small vessels disease (CSVD) and the dysfunction of brain barriers.

The present call aims to fund preclinical and clinical research addressing the pathophysiology and therapeutic developments for stroke and other cerebrovascular diseases. Proposals relating CSVD and the dysfunction of brain barriers to cerebrovascular disease are encouraged. Research areas may cover a broad range of aspects associated with cerebrovascular disease such as genetic, epigenetic, molecular mechanism of disease. Neuroinflammatory processes often play an important role in cerebrovascular diseases and are included in the call. The development of preventive, diagnostic or therapeutic approaches including pharmacological studies (e.g. on drug target identification) and technological developments based on pathophysiological mechanisms are within the scope of the call.

The call will accept research proposals ranging from understanding basic mechanisms of cerebrovascular disease and brain barriers dysfunctions through proof-of-concept clinical studies in humans.

Hard Facts:

Joint projects with a minimum of three and maximum of five to six partners from at least three eligible countries
Funding via DFG or BMBF
Max. EUR 360,000 German funding per consortium
20 % / 22 % Overhead
08.03.2022 - Deadline for pre-proposal
28.06.2022 - Deadline for full-proposal

Participating Countries:

Belgium, Canada, Croatia, Estonia, France, Germany, Hungary, Israel, Italy, Latvia, Norway, Poland, Romania, Slovakia, Spain, Switzerland, Taiwan, Turkey